You are here

  • Home
  • Archive
  • Volume 97, Issue 8
  • Cost-effectiveness of two screening strategies for Chlamydia trachomatis and Neisseria gonorrhoeae as part of the PrEP programme in the Netherlands: a modelling study

Article info

Article menu
Download PDFPDF
Epidemiology
Original research
Cost-effectiveness of two screening strategies for Chlamydia trachomatis and Neisseria gonorrhoeae as part of the PrEP programme in the Netherlands: a modelling study

Authors

  • Francine van Wifferen Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands PubMed articlesGoogle scholar articles
  • Elske Hoornenborg Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Maarten F Schim van der Loeff Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Janneke Heijne Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands PubMed articlesGoogle scholar articles
  • Albert Jan van Hoek Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Elske Hoornenborg, Department of Infectious Diseases, Public Health Service of Amsterdam, 1018 WT Amsterdam, Netherlands; ehoornenborg{at}ggd.amsterdam.nl
View Full Text

Citation

van Wifferen F, Hoornenborg E, Schim van der Loeff MF, et al
Cost-effectiveness of two screening strategies for Chlamydia trachomatis and Neisseria gonorrhoeae as part of the PrEP programme in the Netherlands: a modelling study
Sexually Transmitted Infections 2021;97:607-612.

Publication history

  • Received August 11, 2020
  • Revised November 27, 2020
  • Accepted December 6, 2020
  • First published January 11, 2021.
Online issue publication 
January 07, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.